ÂÜÀòÂÒÂ×

Kent Durbin is the current Chief Financial Officer at Douglas Pharmaceuticals. Kent has been in this role since March 2014, and was previously the Group Financial Controller at the company from June 2005 to February 2014. Prior to their time at Douglas Pharmaceuticals, Kent worked as a Business Analyst for International Gaming at SKYCITY Entertainment Group from March 2004 to May 2005. Kent has also held positions as Senior Manager at THM Partners LLP from August 2001 to December 2003, and Manager of Transaction Support at EY from February 1999 to February 2001. Kent began their career as an Auditor/Consultant at EY in February 1995 and remained there until December 1998.

Kent Durbin has a PGCertBus in Accounting from Massey University, a CA in Finance and Accounting from Chartered Accountants Australia and New Zealand, and a BCom in Accounting from The University of Auckland. Kent also has a PGCertBus from Northcote College and a CA in Finance and Accounting from Saint Kentigern.

Their manager is Jeff Douglas, Managing Director. They are on a team with Scott Sherriff - Chief Commercial Officer, Peter Surman - Chief Scientific Officer, and Michael Metzler - Director of Manufacturing.